As of 2026-06-18, the EV/EBITDA ratio of Vir Biotechnology Inc (VIR) is -2.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIR's latest enterprise value is 1,294.28 mil USD. VIR's TTM EBITDA according to its financial statements is -468.30 mil USD. Dividing these 2 quantities gives us the above VIR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 17.1x | 14.5x |
| Forward P/E multiples | 14.2x - 17.5x | 15.2x |
| Fair Price | (37.75) - (45.86) | (39.61) |
| Upside | -505.9% - -593.1% | -525.9% |
| Date | EV/EBITDA |
| 2026-06-17 | -2.76 |
| 2026-06-16 | -2.52 |
| 2026-06-15 | -2.52 |
| 2026-06-12 | -2.52 |
| 2026-06-11 | -2.48 |
| 2026-06-10 | -2.39 |
| 2026-06-09 | -2.48 |
| 2026-06-08 | -2.46 |
| 2026-06-05 | -2.53 |
| 2026-06-04 | -2.71 |
| 2026-06-03 | -2.57 |
| 2026-06-02 | -2.56 |
| 2026-06-01 | -2.67 |
| 2026-05-29 | -2.85 |
| 2026-05-28 | -2.85 |
| 2026-05-27 | -2.69 |
| 2026-05-26 | -2.79 |
| 2026-05-22 | -2.72 |
| 2026-05-21 | -2.67 |
| 2026-05-20 | -2.61 |
| 2026-05-19 | -2.49 |
| 2026-05-18 | -2.57 |
| 2026-05-15 | -2.58 |
| 2026-05-14 | -2.69 |
| 2026-05-13 | -2.77 |
| 2026-05-12 | -2.80 |
| 2026-05-11 | -2.76 |
| 2026-05-08 | -2.70 |
| 2026-05-07 | -2.75 |
| 2026-05-06 | -3.12 |
| 2026-05-05 | -3.02 |
| 2026-05-04 | -3.08 |
| 2026-05-01 | -3.02 |
| 2026-04-30 | -3.09 |
| 2026-04-29 | -3.04 |
| 2026-04-28 | -3.12 |
| 2026-04-27 | -3.25 |
| 2026-04-24 | -3.15 |
| 2026-04-23 | -3.14 |
| 2026-04-22 | -3.26 |
| 2026-04-21 | -3.31 |
| 2026-04-20 | -3.41 |
| 2026-04-17 | -3.29 |
| 2026-04-16 | -3.13 |
| 2026-04-15 | -3.18 |
| 2026-04-14 | -3.03 |
| 2026-04-13 | -2.77 |
| 2026-04-10 | -2.84 |
| 2026-04-09 | -2.95 |
| 2026-04-08 | -2.84 |